This is the best summary I could come up with:

On an October evening last year, Summer Moses stood at her partner’s bedside in the intensive care unit of a hospital in Spain and agreed the life support systems could be switched off.

ADAF is taking legal action over the use of the drug in Spain and briefed a British consul from the Foreign, Commonwealth and Development Office on the case in November.

Brooks, 42, a handyman and gardener who lived in Ciudad Quesada in Alicante and was originally from Chesterfield in Derbyshire, suffered a suspected reaction after the metamizole injection at a local clinic.

Spain’s medicine and health products agency, the AEMPS, says the risk of agranulocytosis from metamizole, in which white blood cells are severely depleted, is very rare, in the range of one to 10 cases per million users.

A 2009 study at the Costa del Sol hospital in Marbella concluded: “Dipyrone-related agranulocytosis is an adverse effect more frequent in [the] British population, and its use must be avoided.”

Vicente Palop Larrea, a doctor specialising in fibromyalgia who helped set up the Valencia region’s pharmaceutical safety authority in the 1980s, said: “Metamizole continues to be dispensed without a prescription.

The original article contains 1,350 words, the summary contains 192 words. Saved 86%. I’m a bot and I’m open source!